SR
Surrozen, Inc. Warrant (SRZNW)
NASDAQ·Healthcare·Biotechnology
$0.01
-51.56%
Mkt Cap $138.86K
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$253.00
Range $171.60 – $297.00
Implied Upside
+4080545.2%
Consensus $253.00 vs current $0.01